Achyranthes Bidentata Extract Market - Forecast(2024 - 2030)

Report Code: FBR 0536 Report Format: PDF + Excel

Achyranthes Bidentata Extract Market Overview

Achyranthes bidentata Extract Market size is estimated to reach $13.2 billion by 2027, growing at a CAGR of 4.5% during the forecast period 2022-2027. Achyranthes bidentata can be delineated as a flowering plant or herb which belongs to the Amaranthaceae family and exhibit several medicinal properties. Saponin like achyranthes bidentata has all-embracing applications in outmoded Chinese therapeutic treatments. Liquid decoctions of achyranthes bidentata which are fabricated by smashing the roots and then administrating with boiling water, are the most common form of herbal medicines and are usually consumed orally. These plants contain products like triterpenoid saponins that hold properties to alter the adverse effects of morbific bacteria. Saponins extend several applications in diminishing cancer risks. Moreover, they help in treating blood anomalies by lowering the lipids in blood and impeding the accretion of the platelet. Saponins are equivalent to an antidote in order to treat someone inflicted with lead poisoning. Considering the widescale application of such analgesics in pharmaceuticals, the achyranthes bidentata extracts market outlook is fairly captivating. The augmenting cerebrovascular diseases, blood disorders, cancer prevalence, and arthritis are factors set to drive the growth of the Achyranthes Bidentata Extract Market for the period 2022-2027.

Report Coverage

The report: “Achyranthes Bidentata Extract Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the Achyranthes Bidentata Extract Market.

By Product Type: Organic and Inorganic.
By FormSolid, Powder, and Fluid/Liquid.
By Geography: North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America) and Rest of World (the Middle East and Africa).

Key Takeaways

  • Geographically, the Asia-Pacific Achyranthes Bidentata Extract Market accounted for the highest revenue share in 2021 and it is poised to dominate the market over the period 2022-2027.
  • Enlarging complications of dental caries and other serious health hitches is said to be a preeminent driver in Asian countries driving the growth of the Achyranthes Bidentata Extract Market. Lack of consciousness among people regarding such herbal plants and Inadequate availability is said to reduce the market growth.
  • Detailed analysis on the Strength, Weaknesses, and Opportunities of the prominent players operating in the market will be provided in the Achyranthes Bidentata Extract Market report.

Achyranthes Bidentata Extract Market Share, By Region (%) in 2021


For More Details on This Report - Request for Sample

Achyranthes Bidentata Extract Market Segment Analysis - By Form

The Achyranthes Bidentata Extract Market based on the form type can be further segmented into solid, powder, and fluid/liquid. The powder segment held the largest share in 2021. The growth is owing to several advantages of powder form over other forms of medicines. The powder is proved to showcase more stability both chemically and physically as compared to liquid forms. On another hand, powder exhibit longer shelf life which makes them more preferred over other alternatives. Moreover, they are less prone to bacterial adulterations, therefore, they are suitable for geriatrics and children. A study has found that patients' bodies absorb power dosage on a dime because of the higher dissolution rate. Nevertheless, the powder and liquid form segment is estimated to be the fastest-growing segment with a CAGR of 5.6% over the forecast period 2022-2027. This growth is owing to the rising usage of powder and liquid extracts in the preparation of beverages and syrups. The demand for organic achyranthes powders is augmenting as people become more aware of their physical well-being. On another hand, liquid decoctions of achyranthes roots can be achieved easily at home which is another major reason stimulating the growth of liquid forms.

Achyranthes Bidentata Extract Market Segment Analysis - By Application

The Achyranthes Bidentata Extract Market based on the application can be further segmented into the beauty/cosmetic industry, pharmaceuticals, food and beverages industry, and others. The pharmaceutical segment held the largest share in 2021. The growth is owing to plunging demand for herbal medications due to their effectiveness. Considering the jaw-dropping intensifications in the prevalence of arthritis, cancer, and cerebrovascular ailments such as stenosis and thrombosis, the overall demand for achyranthes tablets is proliferating. Furthermore, the pharmaceutical segment is estimated to be the fastest-growing segment with a CAGR of 5.3% over the forecast period 2022-2027. If we consider the usage of acyranthes in other industries like food and beverages, and cosmetics, then its usage is limited. It is used in the fabrications of some beverages and beauty products only but the magnitude at which it is used as therapeutics can catch anybody off guard.

Achyranthes Bidentata Extract Market Segment Analysis - By Geography

The Achyranthes Bidentata Extract Market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. Asia-Pacific held the largest share with 37% of the overall market in 2021. The growth in this segment is owing to the factors such as geographical belonging to the Asian continent. Achyranthes Aspera is found only in a few Asian countries like China, India, and Nepal. Moreover, the culture of using traditional medicines and Ayurveda is still prevailing in these countries which makes the herbal plant market a significant alternative to contemporary medicines. Many patients choose to undergo traditional and ayurvedic treatments to elude the side effects of modern drugs. Moreover, Asia-Pacific and Africa are expected to be the fastest-growing segments over the forecast period 2022-2027. This growth is owing to cheaper prices and easy availability even in rural areas. A large fraction of the total population in many Asian and African countries still live in rural areas where herbal medicines are used tremendously. Whereas, western countries are still skeptical about such herbs.

Achyranthes Bidentata Extract Market Drivers

Proliferating health complications are Anticipated to Boost Product Demand. 

With Swift modernization and growing conveniences, several diseases have come into existence out of nowhere and the world is reeling under their sheer weight. The prevalence of cerebrovascular maladies (=embolism, stenosis, hemorrhage, and others), cancer, joint abnormalities (=arthritis), and others is budding. Ischemic strokes are the most frequent cerebrovascular ailment which erupts from blockage of blood vessels. About 87% of strokes fall under the category of ischemic. Whereas, around 35-40% of trauma deaths occur due to hemorrhage. Talking about joint abnormalities like arthritis isn’t too far behind. In 2021 over 340 million cases of arthritis were diagnosed. Consequently, the demand for herbal medicines like achyranthes bidentata is accruing day after day fueling the market growth.

Affordable prices and growing research activities in traditional medications are Expected to Boost Product Demand.

Accruing cost of healthcare throughout the globe, especially in North American countries like the U.S. is giving people a lot of stress. The extortionate cost of modern medications and treatments is turning many people towards traditional medicines. According to a report, around 56-60% of consumers in the U.S. used natural remedies in 2021. Moreover, more than 65% of Indians i.,e, that is around 1 billion people undergo non-allopathic treatments. On another hand, considering the growing demand for traditional medicines, the research activities are heightening worldwide which is acting as a prominent driver in the growth of the achyranthes bidentata extracts market.

Achyranthes Bidentata Extract Market Challenges

Limited production and environmental challenges are Anticipated to Hamper Market Growth.

The achyranthes bidentata has a very limited production as it is found only in a few Asian countries including India, China, and Nepal. Therefore, the supply chain is totally dependent upon 3 or 4 nations. As there is a saying which goes “never put all your eggs in the same basket”, referring to that diversification is important. However, herbal medicines industries operating throughout the globe have no choice as the herb exists only in the Asian continent. On another hand, climatic anomalies such as excess rain, droughts, and disturbed seasonal balance are deteriorating the yield of achyranthes bidentata thus impeding the market growth.

Achyranthes Bidentata Extract Industry Outlook:

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Achyranthes Bidentata Extract Market. Key companies of this market encompass:

  1. Blackmores Ltd.
  2. Mayway Copropration
  3. Lanzhou Wallets Biotech
  4. Cactus Botanics
  5. Hawaii-pharm
  6. Novoherb Technologies
  7. Schaper & Brummer
  8. The Good Scents Company
  9. Botanical Cube Inc.
  10. RD Health Ingredients Co., Ltd.

Recent Developments

  • On June 16, 2021, after 35 relevant clinical trials, researchers in India discovered the high efficacy of a total of 22 traditional Indian herb plants including “Achyranthes Bidentata” against severe acute respiratory syndrome, COVID-19, and influenza. The researcher claimed that these herbs have proper potential in generating more effective treatment therapies.
  • On April 23, 2021, Germany-based “Schaper & Brummer”, a company which is specialized in herbal medicines announced its acquisition by German health care firm “Medice Arzneimittel Puetter.” In this transaction, Medice acquired a controlling stake by purchasing 60% of the shares for an undisclosed price.
  • On October 27, 2020, New South Wales, Australia-based health supplement firm “Blackmores” announced the disinvestment of one of its subsidiaries “Global Therapeutics” to Australian health corporation “McPherson’s Ltd.” Global therapeutics is famous for its Chinese herbal therapeutic medications. Blackmores will receive $27 million for this transaction.

Relevant Links:

Therapeutic Nuclear Medicines Sales Market – Forecast (2022 - 2027)

Report Code: HCR 90937

Gouty Arthritis Market – Forecast (2022 - 2027)

Report Code: HCR 0924

Plant Extracts Market - Forecast(2022 - 2027)

Report Code: FBR 0014

For more Food and Beverage Market reports, please click here

1. Achyranthes Bidentata Extract Market Overview
    1.1 Definitions and Scope
2. Achyranthes Bidentata Extract Market - Executive Summary
3. Achyranthes Bidentata Extract Market– Market Landscape
    3.1 Company Benchmarking- Key Companies
    3.2 Key Company Financial Analysis
    3.3 Market Share Analysis
    3.4 Patent Analysis-Global
    3.5 Pricing Analysis (Comparison of General Price Offerings in the Market)
4. Achyranthes Bidentata Extract Market– Startup Company Scenario (Premium)
    4.1 Investment
    4.2 Revenue
    4.3 Venture Capital and Funding Scenario
5. Achyranthes Bidentata Extract Market– Industry Market Entry Scenario Premium (Premium)
    5.1 Regulatory Scenario
    5.2 New Business and Ease of Doing business index-Global
    5.3 Case Studies of Successful Ventures
6. Achyranthes Bidentata Extract Market- Market Forces
    6.1 Market Drivers
    6.2 Market Constraints
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Achyranthes Bidentata Extract Market– By Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle Analysis
8. Achyranthes Bidentata Extract Market - By Product Type (Market Size –$Million/$Billion) 
    8.1 Organic
    8.2 Inorganic
9. Achyranthes Bidentata Extract Market - By Form (Market Size –$Million/$Billion) 
    9.1 Solid
    9.2 Powder
    9.3 Fluid/Liquid.
10. Achyranthes Bidentata Extract Market – By Application (Market Size –$Million/$Billion) 
    10.1 Beauty/Cosmetic Industry
    10.2 Pharmaceuticals
    10.3 Food and Beverages Industry
    10.4 Others
11. Achyranthes Bidentata Extract Market- By Geography (Market Size -$Million/Billion)
    11.1 North America
        11.1.1 U.S
        11.1.2 Canada
        11.1.3 Mexico 
    11.2 Europe
        11.2.1 Germany
        11.2.2 France
        11.2.3 UK
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Russia
        11.2.7 Rest of Europe
    11.3 Asia-Pacific
        11.3.1 China
        11.3.2 Japan
        11.3.3 South Korea
        11.3.4 India
        11.3.5 Australia & New Zealand
        11.3.6 Rest of Asia-Pacific 
    11.4 South America
        11.4.1 Brazil
        11.4.2 Argentina
        11.4.3 Chile
        11.4.4 Colombia
        11.4.5 Rest of South America
    11.5 Rest of World
        11.5.1 Middle East
        11.5.2 Africa
12. Achyranthes Bidentata Extract Market- Market Entropy
    12.1 New product launches
    12.2 M&A's, collaborations, JVs and partnerships
13. Achyranthes Bidentata Extract Market– Industry Competition Landscape (Premium)
    13.1 Market Share Analysis
        13.1.1 Global Market Share – Key Companies
        13.1.2 Market Share by Region – Key Companies
        13.1.3 Market Share by Countries – Key Companies
    13.2 Competition Matrix
    13.3 Best Practices for Companies
14. Achyranthes Bidentata Extract Market– Key Company List by Country Premium (Premium)
15. Achyranthes Bidentata Extract Market- Company Analysis
    15.1 Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10 Company 10
"*Financials would be provided on a best-efforts basis for private companies*"